Thomas Meyer | Founder, Chairman & CEO |
Covadonga Paneda | Chief Operating Officer |
Good morning, and welcome to the Altamira Therapeutics First Half 2023 Financial Results and Business Update Conference Call. On today's call are Thomas Meyer, Altamira Therapeutics' Founder, Chairman and Chief Executive Officer; and Covadonga Paneda, Chief Operating Officer. Earlier today, Altamira Therapeutics issued a news release with the first half 2023 financial results as well as a comprehensive business update. The release is available on the company's website at ir.altamiratherapeutics.com and has been filed with the SEC.
During today's call, the company will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.